These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8045054

  • 1. Therapeutic approaches in cutaneous lymphoma.
    Jörg B, Kerl H, Thiers BH, Bröcker EB, Burg G.
    Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
    [Abstract] [Full Text] [Related]

  • 2. Treatment of cutaneous T-cell lymphoma.
    Zackheim HS.
    Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Lymphomas of the skin].
    Nagatani T, Baba N, Nakajima H.
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1308-13. PubMed ID: 7688500
    [Abstract] [Full Text] [Related]

  • 10. Current management strategies for cutaneous T-cell lymphoma.
    Knobler E.
    Clin Dermatol; 2004 Aug; 22(3):197-208. PubMed ID: 15262305
    [Abstract] [Full Text] [Related]

  • 11. Treatment of cutaneous T cell lymphoma: current status and future directions.
    Apisarnthanarax N, Talpur R, Duvic M.
    Am J Clin Dermatol; 2002 Aug; 3(3):193-215. PubMed ID: 11978140
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous T cell lymphoma: update of treatment.
    Zackheim HS.
    Dermatology; 1999 Aug; 199(2):102-5. PubMed ID: 10559573
    [Abstract] [Full Text] [Related]

  • 13. Management of refractory early-stage cutaneous T-cell lymphoma.
    Huber MA, Staib G, Pehamberger H, Scharffetter-Kochanek K.
    Am J Clin Dermatol; 2006 Aug; 7(3):155-69. PubMed ID: 16734503
    [Abstract] [Full Text] [Related]

  • 14. Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL).
    Dummer R.
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S33-6. PubMed ID: 16516674
    [Abstract] [Full Text] [Related]

  • 15. Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies.
    Duvic M.
    Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):33-40. PubMed ID: 17474358
    [Abstract] [Full Text] [Related]

  • 16. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L.
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [Abstract] [Full Text] [Related]

  • 17. The role of phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ, Baldwin BT, Cherpelis BS, Lien MH, Fenske NA.
    J Drugs Dermatol; 2010 Jul; 9(7):764-72. PubMed ID: 20677530
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series.
    Singh F, Lebwohl MG.
    J Am Acad Dermatol; 2004 Oct; 51(4):570-3. PubMed ID: 15389192
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of cutaneous T cell lymphomas with PUVA.
    Rabbiosi G, Carcaterra A, Bellosta M.
    Int J Tissue React; 1986 Oct; 8(2):141-3. PubMed ID: 3486168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.